NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Aldeyra Therapeutics, Inc. Share Price Chart

O H L

Aldeyra Therapeutics, Inc. Performance Overview

Days Range
$1.38Low
$1.38High

Markets Today

Previous Close$1.38
Open$1.38
Volume38,849
Day's Range$1.38 - $1.38
52W Range$1.07 - $5.93
Market Cap$82.65 M

Historical Performance

1M Returns-10.97
3M Returns-29.59
6M Returns-2.82
1Y Returns-72.46
5Y Returns-83.90
10Y Returns-79.91

Aldeyra Therapeutics, Inc. Fundamentals

Market Cap$82.65 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-0.59
EPS TTM$-0.38
Quarterly Earnings Growth YOYN/A
PB Ratio2.18
EBITDA$-35.01 M
Profit MarginN/A
Market Cap$82.65 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-0.59
EPS TTM$-0.38
Quarterly Earnings Growth YOYN/A
PB Ratio2.18
EBITDA$-35.01 M
Profit MarginN/A

Aldeyra Therapeutics, Inc. Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$0$0$0$0$0
Gross Profit +$0$0$0$0$0$0
Operating Income -$10.43 M-$10.17 M-$8.00 M-$6.67 M-$3.55 M-$5.85 M
EBITDA -$10.37 M-$10.11 M-$7.94 M-$6.60 M-$3.48 M-$5.78 M
Interest Expense -$483.53 K-$470.62 K-$475.90 K-$475.26 K-$468.68 K-$23
Depreciation $60.91 K$62.28 K$63.68 K$65.12 K$66.60 K$70.71 K
Income Before Tax -$9.93 M-$9.77 M-$7.69 M-$6.46 M-$3.45 M-$5.45 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$9.93 M-$9.77 M-$7.69 M-$6.46 M-$3.45 M-$5.45 M
Net Profit Margin ------

Aldeyra Therapeutics, Inc. Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $60.05 K$60.05 K$60.16 K$60.16 K$60.32 K$60.32 K
Reserve & Surplus -$460.04 M-$469.82 M-$477.49 M-$483.96 M-$487.41 M-$492.86 M
Non-Current Liabilities $15.31 M$143.45 K$72.54 K$0$0$0
Current Liabilities $14.29 M$29.53 M$28.48 M$27.81 M$24.33 M$9.66 M
Total Liabilities $29.60 M$29.67 M$28.56 M$27.81 M$24.33 M$9.66 M
Fixed Assets $0$0$0$0$0$20.54 K
Current Assets $92.73 M$84.56 M$77.46 M$71.78 M$66.27 M$47.38 M
Total Assets $93.20 M$84.96 M$77.80 M$72.06 M$66.48 M$47.54 M

Aldeyra Therapeutics, Inc. Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$9.93 M-$9.77 M-$7.69 M-$6.46 M-$3.45 M-$5.45 M
Operating Cash Flow -$12.47 M-$8.56 M-$7.02 M-$5.30 M-$5.11 M-$4.59 M
Investing Cash Flow $7.29 M-$554.13 K$25.00 M$16.00 M$0-$23.10 K
Financing Cash Flow $1.00 M$0$120.75 K$0$71.14 K-$15.30 M
Change in Cash -$4.18 M-$9.11 M$18.10 M$10.70 M-$5.04 M-$19.91 M

Aldeyra Therapeutics, Inc. Return Calculator

The Aldeyra Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$1,599
Invested Amount$10,000
Est. Returns$-8,401
Invest in USA Stock Today

About Aldeyra Therapeutics, Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

FAQs

Aldeyra Therapeutics, Inc. (ALDX) share price as of September 18, 2026 is $1.37. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Aldeyra Therapeutics, Inc. (ALDX) Share by opening an international trading account with Angel One.
Purchasing Aldeyra Therapeutics, Inc. (ALDX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Aldeyra Therapeutics, Inc. (ALDX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Aldeyra Therapeutics, Inc. (ALDX) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Aldeyra Therapeutics, Inc. on September 18, 2026, is $82.65 M.
Aldeyra Therapeutics, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Aldeyra Therapeutics, Inc. (ALDX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91